MS News & Perspectives

MS News & Perspectives

By MS News TodayScience
Download on the App Store

MS News & Perspectives episodes

  • Combo of Biomarkers Predicts Future Disease Activity & John Connor Gets A New Hairstyle
    Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how high levels of neurofilament light chain (NfL) protein combined with thinning of the retina can be a strong indicator of future disease activity; and reads the column by John Connor, Fall Down, Get Up Again, “Lockdown Blues: Well That Was a Close Shave!”.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
    Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
    https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
    https://multiplesclerosisnewstoday.com/
    =====================================To join in on conversations regarding multiple sclerosis, please visit:
    https://multiplesclerosisnewstoday.com/forums/
    15 min
  • FDA to Review ANI’s Request for Cortrophin Gel Use & Amazon Care to Expand Into Healthcare Services
    Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article, “FDA to Review ANI’s Request for Cortrophin Gel Use” and reads the column by Ed Tobias, MS Wire, “Amazon Care to Expand Company’s Reach Into Healthcare Services”.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
    Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
    https://www.mayzent.com/?utm_source=changeinrms_url&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020 ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
    https://multiplesclerosisnewstoday.com/
    =====================================To join in on conversations regarding multiple sclerosis, please visit:
    https://multiplesclerosisnewstoday.com/forums/
    9 min
  • Early High-efficacy DMTs Linked to Better RRMS Outcomes in Sweden & Being Enough With MS
    Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how early high-efficacy disease modifying therapies (DMTs) are linked to better outcomes in patients with Relapsing-Remitting Multiple Sclerosis (RRMS) and reads “MS Doesn’t Get to Decide Whether We Are Enough”, a column by Jennifer Powell.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
    Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
    https://www.mayzent.com/?utm_source=changeinrms_url&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020 ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
    https://multiplesclerosisnewstoday.com/
    =====================================To join in on conversations regarding multiple sclerosis, please visit:
    https://multiplesclerosisnewstoday.com/forums/
    10 min
  • Interferon Beta-1b Effective, Safe for Older MS Patients & John Connor's Latest Column
    Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses Interferon Beta-1b, and it’s effectiveness and safety for older Multiple Sclerosis (MS) patients and reads the column by John Connor, Fall Down, Get Up Again, “I’ve Nothing Awful to Write About My MS This Week”.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
    Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
    https://www.mayzent.com/?utm_source=changeinrms_url&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020 =====================================

    Are you interested in learning more about multiple sclerosis? If so, please visit:
    https://multiplesclerosisnewstoday.com/
    =====================================
    To join in on conversations regarding multiple sclerosis, please visit:
    https://multiplesclerosisnewstoday.com/forums/
    13 min
  • Moderate-To-Severe Bowel Problems Found in 14.5% Of People with MS & Ed Tobias’ Latest Column
    Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses moderate-to-severe bowel problems found in 14.5% of people with Multiple Sclerosis (MS) and reads the column by Ed Tobias, MS Wire, “Humana’s Lawsuit Against Biogen Decries Ongoing ‘Seed and Sweep’ Schemes”.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
    Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
    http://ChangesInRMS.com
    =====================================
    Are you interested in learning more about multiple sclerosis? If so, please visit:
    https://multiplesclerosisnewstoday.com/
    =====================================
    To join in on conversations regarding multiple sclerosis, please visit:
    https://multiplesclerosisnewstoday.com/forums/
    6 min
  • Landos Biopharma and Johns Hopkins School of Medicine Partner to Advance Oral Therapy
    Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses Landos Biopharma and Johns Hopkins School of Medicine partnering to advance a potential Multiple Sclerosos (MS) oral therapy & reads the column by Jennifer Powell, Silver Linings, “Are You Prepared for a Fall?”===================================
    Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
    Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
    http://ChangesInRMS.com
    =====================================
    Are you interested in learning more about multiple sclerosis? If so, please visit:
    https://multiplesclerosisnewstoday.com/
    =====================================
    To join in on conversations regarding multiple sclerosis, please visit:
    https://multiplesclerosisnewstoday.com/forums/
    9 min
  • Discussing MS Patients in the United States Who May Lack Key Insurance Coverage
    Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses Multiple Sclerosis (MS) patients in the United States who may lack key insurance coverage and reads the column by John Connor, Fall Down, Get Up Again, “Be Warned: Another Column All About My MS and Me!”===================================
    Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
    Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
    http://ChangesInRMS.com
    =====================================
    Are you interested in learning more about multiple sclerosis? If so, please visit:
    https://multiplesclerosisnewstoday.com/
    =====================================
    To join in on conversations regarding multiple sclerosis, please visit:
    https://multiplesclerosisnewstoday.com/forums/
    12 min
  • Pain, Fatigue And Anxiety Are Common in The First Year After CIS/MS Diagnosis
    Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how pain, fatigue, and anxiety are common in the first year after a Multiple Sclerosis (MS) diagnosis.Price also reads the column by Ed Tobias, MS Wire, “Are Generic and Brand-name Pills Created Equal?”===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
    Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
    https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
    https://multiplesclerosisnewstoday.com/
    =====================================To join in on conversations regarding multiple sclerosis, please visit:
    https://multiplesclerosisnewstoday.com/forums/
    12 min
  • Interview With MS Patient and Actor Damian Washington
    Join us as Jenn Powell speaks with multiple sclerosis patient and actor Damian Washington.Damian Washington has had MS for 6 years. But that doesn’t stop this actor, rapper, and self-described nerd from living his best life. Listen as Damian shares his MS experience, from first symptoms and diagnosis to learning to be his own advocate. Damian speaks candidly about how the landscape of clinical trials for MS need to address inclusivity, and how African American’s need equal representation. Warning: you may laugh. A lot.Damian Washington is actor from New York City and has appeared in over 30 commercials and voiceovers for brands like McDonalds, AT&T and Planet Fitness. His YouTube channel NoStressMS, about life with multiple sclerosis, has over 5,000 subscribers and won a 2020 WEGO Health Award for Best in Show. Viewers say the channel helps bring levity to the often-grim topic of autoimmune disease.Find out more about Damian Washington at: https://www.damianwashington.com/
    Join the conversation on our MS forums: www.multiplesclerosisnewstoday.com/forums/
    Follow us on social media:
    Instagram - www.instagram.com/msnewstoday/
    Facebook - www.facebook.com/multiplesclerosisnewstoday
    Twitter - www.twitter.com/msnewstoday
    For more news on Multiple Sclerosis visit:
    www.multiplesclerosisnewstoday.com/
    45 min
  • Probiotics Likely To Be of Help With RRMS, Meta-analysis Finds
    Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how probiotics are likely to be of help with relapsing-remitting multiple sclerosis (RRMS). He also reads “I Am Proud of the Disability I Once Feared”, a column by Jennifer Powell.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
    Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
    https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
    https://multiplesclerosisnewstoday.com/
    =====================================To join in on conversations regarding multiple sclerosis, please visit:
    https://multiplesclerosisnewstoday.com/forums/
    10 min

About MS News & Perspectives

From the publisher's feed

Multiple Sclerosis News Today seeks to fill an unmet need in healthcare news journalism by providing patients and their families with a reliable news journal on MS that they can engage with on a daily…

More shows like MS News & Perspectives

The Diary Of A CEO with Steven Bartlett by DOAC

The Diary Of A CEO with Steven Bartlett

8,428 Listeners